Kimia Biosciences insider trading and stake changes
BSE: 530313Pharmaceuticals & BiotechnologySmall Cap
Last close ₹29.99down ₹0.06 (0.20%)
Share price at the BSE close on 23 Oct 2026. Previous close ₹30.05.
52-week range of traded prices to 23 Oct 2026
₹23.20Low, 30 Mar 2026₹43.28High, 16 Feb 2026
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹142 Cr2,580th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. The filing of 10 Aug 2026
- 19.7
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 30 May 2026
- 8.0
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 10 Aug 2026
- 51.9%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 10 Aug 2026
- 19.1%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 30 May 2026
- 1.95
- Volume, BSEVolume. Shares traded on the last trading day.
- 1,361
Kimia Biosciences insider trading
All 13 disclosures on record. The company's own latest disclosure on record is from Jul 2022.Insider trading, all companies
Jul 2022
- DEEPA GOEL₹18 Cr53,18,380 sharesReceived · Promoter · 2 Jul 2022 · disclosed 4 Jul · Inheritance · held 16 before, holds 53,18,396 after, stake 11.25% after
Jun 2020
- SAMEER GOEL₹2.93 Cr9,58,790 sharesReceived · Promoter and Director · 26 Jun 2020 · disclosed 29 Jun · Conversion of security · held 2,91,78,591 before, holds 3,01,37,381 after, stake 63.70% after
Jan 2020
- SAMEER GOEL₹11 Cr55,30,000 sharesReceived · Promoter and Director · 28 Jan 2020 · disclosed 30 Jan · Conversion of security · held 2,36,48,591 before, holds 2,91,78,591 after, stake 62.95% after
Jul 2019
- SACHIN GOEL₹8.73 Cr34,92,920 sharesReceived · Promoter · 1 Jul 2019 · disclosed 3 Jul · Allotment · held 17,95,960 before, holds 52,88,880 after, stake 12.96% after
- SAMEER GOEL₹21 Cr85,07,080 sharesReceived · Promoter and Director · 1 Jul 2019 · disclosed 3 Jul · Allotment · held 1,51,41,511 before, holds 2,36,48,591 after, stake 57.97% after
Jun 2019
- SAMEER GOEL₹13 Cr42,53,540 sharesReceived · Director · 19 Jun 2019 · disclosed 21 Jun · Allotment · held 1,08,87,971 before, holds 1,51,41,511 after, stake 64.91% after
- SACHIN GOEL₹5.24 Cr17,46,460 sharesReceived · Promoter · 19 Jun 2019 · disclosed 21 Jun · Allotment · held 49,500 before, holds 17,95,960 after, stake 7.70% after
Nov 2018
- Sachin Goel₹0.20 Cr49,500 sharesReceived · Promoter & Director · 19 Nov 2018 · disclosed 21 Nov · Scheme of Amalgamation/Merger/Demerger/Arrangement · held none before, holds 49,500 after, stake 0.34% after
- Sameer Goel₹0.65 Cr64,88,790 unitsReceived · Promoter & Director · 19 Nov 2018 · OCPS Preference Shares · disclosed 21 Nov · Scheme of Amalgamation/Merger/Demerger/Arrangement · held none before, holds 64,88,790 after
- Sachin Goel₹29,50029,500 unitsReceived · Promoter & Director · 19 Nov 2018 · OCPS Preference Shares · disclosed 21 Nov · Scheme of Amalgamation/Merger/Demerger/Arrangement · held none before, holds 29,500 after
- Sameer Goel₹43 Cr1,08,87,971 sharesReceived · Promoter & Director · 19 Nov 2018 · disclosed 21 Nov · Scheme of Amalgamation/Merger/Demerger/Arrangement · held none before, holds 1,08,87,971 after, stake 74.60% after
Earlier, Feb 2018 to Feb 2018Hide earlier
Feb 2018
- Sachin Goel₹1.57 Cr5,23,938 unitsReceived · Promoter · 15 Feb 2018 · Warrants · disclosed 19 Feb · Preferential Offer · holds 5,23,938 after
- Sameer Goel₹3.83 Cr12,76,062 unitsReceived · Promoter · 15 Feb 2018 · Warrants · disclosed 19 Feb · Preferential Offer · holds 12,76,062 after
Trades by the company's promoters, directors, key managers, employees and their relatives, as each disclosed them. Value is what the filer stated; the mode is shown where the shares moved off the market.
Kimia Biosciences stake sales and purchases
All 15 disclosures on record.
Aug 2024
- AcquiredSameer Goel11.24% of the company53,18,395 shares13 Aug 2024 · filed as exempt from an open offer
- AcquiredSameer Goel & PACs · promoter11.24% of the company53,18,395 sharesholds 74.94% after9 Aug 2024 · filed under the 2% rule · Off Market / Inter se transfer
- SoldDeepa Goel · promoter11.24% of the company53,18,395 shares9 Aug 2024 · filed under the 2% rule · Off Market / Inter se transfer
- ProposedSameer Goel · promoter11.24% of the company53,18,395 shares8 Aug 2024 · notice before a transfer exempt from an open offer
Jul 2022
- AcquiredDeepa Goel & PACs (Revised) · promoter11.24% of the company53,18,380 sharesholds 11.25% after2 Jul 2022 · filed under the 2% rule · Transmission
Jun 2020
- AcquiredSameer Goel & PACs · promoter2.03% of the company9,58,790 sharesholds 63.70% after26 Jun 2020 · filed under the 2% rule · Allotment On Conversion Of Ccps
Jan 2020
- AcquiredSameer Goel & PACs · promoter11.99% of the company55,59,530 sharesholds 74.42% after28 Jan 2020 · filed under the 2% rule · Scheme Of Amalgamation
Jul 2019
- AcquiredSameer Goel, Sachin Goel & PACs (Revised) · promoter29.41% of the company1,20,00,000 sharesholds 70.93% after1 Jul 2019 · filed under the 2% rule · Conversion of warrants
Jun 2019
- AcquiredSameer Goel, Sachin Goel & PACs · promoter25.72% of the company60,00,000 sharesholds 72.61% after19 Jun 2019 · filed under the 2% rule · Conversion of warrants
Earlier, Sep 2016 to Nov 2018Hide earlier
Nov 2018
- AcquiredSameer Goel & PACs · promoter74.94% of the company1,09,37,521 sharesholds 74.94% after19 Nov 2018 · filed under the 2% rule · Scheme Of Amalgamation
Sep 2016
- SoldKumar Sahay Verma40.77% of the company30,10,600 shares8 Sep 2016 · filed under the 2% rule · Share purchase agreement
- SoldVandana Varma0.14% of the company10,500 shares8 Sep 2016 · filed under the 2% rule · Share purchase agreement
- SoldBijwasan Agro Ltd6.88% of the company5,08,400 shares8 Sep 2016 · filed under the 2% rule · Share purchase agreement
- SoldAgora Agro Pvt Ltd1.35% of the company1,00,000 shares8 Sep 2016 · filed under the 2% rule · Share purchase agreement
- AcquiredKimia Biosciences Ltd · promoter49.15% of the company36,29,500 sharesholds 50.49% after8 Sep 2016 · filed under the 5% rule · Share purchase agreement
The 5% rule: an investor discloses on reaching 5% of the company. The 2% rule: a holder of 5% or more discloses each change of 2% or more, including one that takes it below 5%. A transfer exempt from an open offer, the offer to buy from every other shareholder that a large purchase otherwise brings, is disclosed too. Each line shows what its filing states, which can be a smaller change than its rule names.